APPARATUS FOR CABLE INSPECTION
    111.
    发明申请
    APPARATUS FOR CABLE INSPECTION 审中-公开
    电缆检查装置

    公开(公告)号:US20170074778A1

    公开(公告)日:2017-03-16

    申请号:US15265141

    申请日:2016-09-14

    Inventor: Jang Bom CHAI

    CPC classification number: G01N17/004 G01R31/021 G01R31/022 G01R31/085

    Abstract: Disclosed is an apparatus for cable inspection, which inspects an aerial cable used in electric power transmission, the apparatus including: first and second plates spaced apart from each other; a lower clamp disposed on the first plate; an upper clamp disposed on the second plate to face the lower clamp and having a through hole in a vertical direction; a distance adjustment unit configured to adjust a separation distance between the first and second plates; an indenter indented in a coating of the cable through the through hole; a first load cell configured to measure an indentation force of the indenter and to output a signal corresponding to the measured indentation force; a second load cell disposed under the lower clamp and configured to measure pressure applied to the cable and to output a signal corresponding to the measured pressure; and an indenter moving unit configured to control movement of the indenter. According to the present invention, deterioration of a cable is measured using a plurality of sensors so that measurement accuracy can be improved and measurement of deterioration of the cable can be performed in a state in which the cable is disposed.

    Abstract translation: 公开了一种用于电力检测的装置,其检查用于电力传输的架空电缆,该装置包括:彼此间隔开的第一和第二板; 设置在第一板上的下夹具; 设置在所述第二板上以与所述下夹具相对并且在垂直方向上具有通孔的上夹具; 距离调节单元,被配置为调整所述第一和第二板之间的间隔距离; 通过通孔在电缆的涂层中凹入的压头; 第一测力传感器,被配置为测量所述压头的压痕力并输出对应于所测量的压痕力的信号; 第二测力传感器,设置在所述下夹具下方并且被配置为测量施加到所述电缆的压力并输出对应于所测量的压力的信号; 以及压头移动单元,其构造成控制所述压头的移动。 根据本发明,使用多个传感器测量电缆的劣化,从而可以提高测量精度,并且可以在布置电缆的状态下进行电缆的劣化的测量。

    Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability
    114.
    发明授权
    Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability 有权
    包含用于抑制SCF或其受体的材料用于治疗或预防与血管通透性相关的疾病的组合物

    公开(公告)号:US09528112B2

    公开(公告)日:2016-12-27

    申请号:US14398531

    申请日:2012-10-25

    Abstract: The present invention relates to a composition comprising a material for inhibiting stem cell factor (SCF) or the receptor thereof for treating or preventing vascular permeability related diseases. Also, the present invention relates to a method for screening for an agent for treating vascular permeability related diseases, comprising the steps of: (a) treating a sample from a patient suspected of having a disease associated with vascular permeability with a candidate material; and (b) comparing the level of expression of the SCF or the receptor thereof with that of a control group. The present invention verifies SCF as a novel target for regulating vascular permeability. When the present invention is used, vascular permeability is decreased in diseases of the eye involving increased vascular permeability, thereby effectively treating or preventing vascular permeability related diseases. Also, vascular permeability can be effectively regulated using the composition. Further, the present invention can be provided as an effective means for screening an agent for treating vascular permeability related diseases by measuring the regulation of the expressions of SCF and c-Kit.

    Abstract translation: 本发明涉及包含用于抑制干细胞因子(SCF)的材料或其受体用于治疗或预防血管通透性相关疾病的组合物的组合物。 此外,本发明涉及一种筛选用于治疗血管通透性相关疾病的药剂的方法,包括以下步骤:(a)用怀疑患有与血管通透性相关的疾病的患者用候选物质处理样品; 和(b)比较SCF或其受体的表达水平与对照组的表达水平。 本发明将SCF验证为调节血管通透性的新靶标。 当使用本发明时,涉及血管通透性增加的眼睛疾病中的血管通透性降低,从而有效地治疗或预防血管通透性相关疾病。 此外,可以使用组合物有效调节血管通透性。 此外,通过测量SCF和c-Kit的表达的调节,本发明可以作为筛选用于治疗血管通透性相关疾病的药剂的有效手段。

    LIFESTYLE ANALYSIS SYSTEM AND METHOD
    115.
    发明申请
    LIFESTYLE ANALYSIS SYSTEM AND METHOD 审中-公开
    生活分析系统和方法

    公开(公告)号:US20160371454A1

    公开(公告)日:2016-12-22

    申请号:US14901561

    申请日:2014-06-25

    Inventor: We Duke CHO

    CPC classification number: G06Q50/01 G06F19/3475 G06Q50/22 G16H50/50

    Abstract: The present invention relates to a technique of managing a lifestyle, and more particularly, to a technique of analyzing a use's tendency by collecting big data of an personal lifestyle, storing a reference model generated by using the big data, and comparing lifelog data collected from the user based on the stored reference model to extract similarity and difference.One aspect of the present invention provides a system for analyzing a lifestyle including a log collecting unit, a reference model storing unit, a pattern extracting unit, a tendency analyzing unit, and a personalized model generating unit.

    Abstract translation: 本发明的一个方面提供了一种用于分析日志收集单元,参考模型存储单元,模式提取单元,趋势分析单元和个性化模型生成单元的生活方式的系统。

    Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
    116.
    发明授权
    Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient 有权
    用于治疗或预防由血管通透性引起的疾病的组合物,其含有伊马替尼或其药学上可接受的盐作为活性成分

    公开(公告)号:US09511068B2

    公开(公告)日:2016-12-06

    申请号:US14409441

    申请日:2013-06-10

    CPC classification number: A61K31/506 C07D401/04

    Abstract: The present invention relates to a pharmaceutical composition for treating or preventing diseases caused by vascular permeability, containing imatinib, which has been conventionally used as an agent for treating chronic myeloid leukemia, or a pharmaceutically acceptable salt thereof as an active ingredient, and a method for treating disease caused by vascular permeability using the composition. The pharmaceutical composition for treating or preventing diseases caused by vascular permeability of the present invention contains imatinib, which has been conventionally used as an agent for treating chronic myeloid leukemia, as an active ingredient, so as to provide a novel use of imatinib and to be able to effectively treat or prevent diseases caused by vascular permeability, and thus may be widely applied to develop a novel agent for treating diseases caused by vascular permeability.

    Abstract translation: 本发明涉及用于治疗或预防由血管通透性引起的疾病的药物组合物,其含有伊马替尼,其通常用作治疗慢性骨髓性白血病的药物或其药学上可接受的盐作为活性成分, 使用该组合物治疗由血管通透性引起的疾病。 用于治疗或预防由本发明的血管渗透性引起的疾病的药物组合物含有作为常规用作治疗慢性骨髓性白血病的药物的伊马替尼作为活性成分,以提供伊马替尼的新用途,并且为 能够有效地治疗或预防由血管通透性引起的疾病,因此可广泛应用于开发用于治疗由血管渗透性引起的疾病的新型药剂。

    Method and apparatus for decoding low-density parity-check code
    117.
    发明授权
    Method and apparatus for decoding low-density parity-check code 有权
    用于解码低密度奇偶校验码的方法和装置

    公开(公告)号:US09503124B2

    公开(公告)日:2016-11-22

    申请号:US14537571

    申请日:2014-11-10

    CPC classification number: H03M13/1131 H03M13/1117 H03M13/6502

    Abstract: Provided is a method of decoding a low-density parity-check code (LDPC). The decoding method including an initialization process, a check node update process, a variable node update process, a tentative decoding process, and a parity check process, for a plurality of check nodes and a plurality of variable nodes, further includes detecting at least one inactive variable nodes that do not require variable node update among the variable nodes, the variable node update process is performed only on active variable nodes except for the inactive variable node, and the check node update process is performed without using the inactive variable node.

    Abstract translation: 提供了一种对低密度奇偶校验码(LDPC)进行解码的方法。 对于多个校验节点和多个可变节点,包括初始化处理,校验节点更新处理,变量节点更新处理,暂定解码处理和奇偶校验处理的解码方法还包括检测至少一个 在变量节点之间不需要变量节点更新的非活动变量节点,仅在非活动变量节点之外的活动变量节点上执行变量节点更新过程,并且不使用非活动变量节点执行校验节点更新过程。

    LIQUID TYPE PLASMA FOR PREVENTING OR TREATING CANCER
    118.
    发明申请
    LIQUID TYPE PLASMA FOR PREVENTING OR TREATING CANCER 有权
    液体等离子体用于预防或治疗癌症

    公开(公告)号:US20160296763A1

    公开(公告)日:2016-10-13

    申请号:US14982948

    申请日:2015-12-29

    CPC classification number: A61N1/44 A61K33/00 H05H1/24 H05H2240/20 H05H2245/122

    Abstract: The present invention relates to a method for preparing a plasma for preventing or treating a cancer. Also, the present invention relates to a liquid type plasma for preventing or treating a cancer prepared by treating the plasma and a pharmaceutical composition for preventing or treating a cancer comprising the same. The plasma and the liquid type plasma according to the present invention can effectively induce cancer cell death without a surgical operation or in a treatment process after a surgical operation, thereby being useful as a novel therapeutic agent and method for a cancer.

    Abstract translation: 本发明涉及一种预防或治疗癌症的血浆的制备方法。 另外,本发明涉及一种用于预防或治疗通过治疗血浆而制备的癌症的液体型等离子体,以及用于预防或治疗包含该癌症的癌症的药物组合物。 根据本发明的等离子体和液体型等离子体可以在外科手术或外科手术后的治疗过程中有效地诱导癌细胞死亡,从而可用作癌症的新治疗剂和方法。

    LIFESTYLE SERVICE DESIGN SYSTEM AND METHOD
    119.
    发明申请
    LIFESTYLE SERVICE DESIGN SYSTEM AND METHOD 审中-公开
    生活服务设计系统和方法

    公开(公告)号:US20160294959A1

    公开(公告)日:2016-10-06

    申请号:US14392268

    申请日:2014-06-25

    Inventor: We Duke CHO

    CPC classification number: H04L67/22 G06Q50/10 G06Q90/00 G16H10/60

    Abstract: The present invention relates to a technique of managing a lifestyle, and the present invention is directed to provide a system and a method for designing a lifestyle service which collects big data of personal lifelogs, collects analysis of personal activities through the collected lifelogs, and estimates possible user's behavior based on the collected analysis of personal activities to induce the user's behavior in a preferable direction which may improve quality of life according to the estimated user's behavior to manage the user's health.

    Abstract translation: 本发明涉及一种管理生活方式的技术,本发明旨在提供一种系统和方法,用于设计收集个人生活日志的大数据的生活方式服务,通过收集的生活日志收集个人活动的分析,并估计 基于收集到的个人活动分析的可能的用户行为,以诱导用户在优选方向上的行为,其可以根据估计的用户的行为改善用户的健康状况来提高生活质量。

Patent Agency Ranking